(19)
(11) EP 2 278 960 A1

(12)

(43) Date of publication:
02.02.2011 Bulletin 2011/05

(21) Application number: 09721703.8

(22) Date of filing: 12.03.2009
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
A61K 31/426(2006.01)
(86) International application number:
PCT/IB2009/051030
(87) International publication number:
WO 2009/115954 (24.09.2009 Gazette 2009/39)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 17.03.2008 WO PCT/IB2008/050995

(71) Applicant: Actelion Pharmaceuticals Ltd.
4123 Allschwil (CH)

(72) Inventors:
  • BROSSARD, Patrick
    CH-4123 Allschwil (CH)
  • DINGEMANSE, Jasper
    CH-4123 Allschwil (CH)
  • NAYLER, Oliver
    CH-4144 Arlesheim (CH)
  • SCHERZ, Michael
    CH-4107 Ettingen (CH)
  • STEINER, Beat
    CH-4143 Dornach (CH)

(74) Representative: Gschwend, Thomas Peter et al
Actelion Pharmaceuticals Ltd Gewerbestrasse 16
CH-4123 Allschwil
CH-4123 Allschwil (CH)

   


(54) DOSING REGIMEN FOR A SELECTIVE SIP1 RECEPTOR AGONIST